Can You Get CMT1A Without a Family History?
At a Glance
Yes, you can get CMT1A without a family history. About 19% of cases are caused by a spontaneous genetic change called a de novo mutation. However, some cases may stem from a hidden family history where a parent had very mild, undiagnosed symptoms.
Yes, it is entirely possible to be diagnosed with Charcot-Marie-Tooth disease type 1A (CMT1A)—a genetic condition affecting the peripheral nerves—even if neither of your parents has the condition [1]. While CMT1A is a genetic disease, approximately 19% of all cases occur because of a spontaneous genetic change—known as a de novo mutation—that happens for the very first time during conception [2].
Understanding De Novo Mutations
CMT1A is most commonly caused by having an extra copy (duplication) of the PMP22 gene, which plays a critical role in maintaining the protective covering around your nerves [3][4]. In most people with CMT1A, this genetic duplication is passed down from a parent [5].
However, in a de novo mutation, the DNA duplication happens spontaneously when the egg or sperm is formed, or very shortly after fertilization [2]. This means the genetic change is completely new to you, and neither of your parents carries the duplicated gene or the disease. It is important to know that these spontaneous changes are natural errors in DNA copying and are not caused by anything your parents did or did not do.
Hidden Family History
While spontaneous mutations account for many cases without a family history, sometimes a lack of family history is actually a “hidden” family history. The symptoms of CMT1A can vary widely from person to person [6]. It is possible that one of your parents or grandparents actually has the PMP22 duplication but experiences symptoms so mild—such as high arches or slight clumsiness—that it was never recognized or was misdiagnosed as something else [7].
Because of this, formal genetic testing of your parents is the only definitive way to confirm whether your case is truly de novo or inherited from a parent with very mild, unrecognized symptoms.
What This Means for Your Future Children
Even if your CMT1A is the result of a spontaneous de novo mutation, the genetic change is now part of your DNA. Because CMT1A is a dominantly inherited condition, an individual only needs to inherit the chromosome with the extra copy of the PMP22 gene to have the disease [5]. This means that if you have children, there is a 50% chance of passing the genetic duplication to each child.
A genetic counselor can help you understand these risks and discuss concrete options for family planning. For example, some individuals with CMT1A opt for in vitro fertilization (IVF) with preimplantation genetic testing, a modern family planning option that can ensure the gene duplication is not passed to the baby.
Common questions in this guide
Can I get CMT1A if no one else in my family has it?
Could my parents have CMT1A without knowing it?
If my CMT1A is a spontaneous mutation, can I still pass it to my children?
How can I know for sure if my CMT1A was inherited or spontaneous?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Should my parents undergo genetic testing or a neurological evaluation to definitively confirm if my mutation is a spontaneous one or an inherited one?
- 2.Could you refer me to a genetic counselor to discuss family planning and the 50% chance of passing this on to my future children?
- 3.Is my prognosis or symptom progression expected to be any different since my mutation might be a spontaneous one?
- 4.Are there specific resources or support groups you recommend to help me explain this genetic diagnosis to my family?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (7)
- 1
Clinical and genetic spectra of Charcot-Marie-Tooth disease in Chinese Han patients.
Sun B, Chen Z, Ling L, et al.
Journal of the peripheral nervous system : JPNS 2017; (22(1)):13-18 doi:10.1111/jns.12195.
PMID: 27862672 - 2
Paternal gender specificity and mild phenotypes in Charcot-Marie-Tooth type 1A patients with de novo 17p12 rearrangements.
Lee AJ, Nam DE, Choi YJ, et al.
Molecular genetics & genomic medicine 2020; (8(9)):e1380 doi:10.1002/mgg3.1380.
PMID: 32648354 - 3
AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cells.
Yoshioka Y, Taniguchi JB, Homma H, et al.
Communications medicine 2023; (3(1)):170 doi:10.1038/s43856-023-00400-y.
PMID: 38017287 - 4
Characterising PMP22-Proximal Partners in a Schwann Cell Model of Charcot-Marie-Tooth Disease Type1A.
Holt I, Emery N, Gates MA, et al.
Biology 2025; (14(11)) doi:10.3390/biology14111552.
PMID: 41300342 - 5
Phosphodiesterase 4D inhibition improves the functional and molecular outcome in a mouse and human model of Charcot Marie Tooth disease 1 A.
Schepers M, Vangansewinkel T, Libberecht K, et al.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025; (183()):117828 doi:10.1016/j.biopha.2025.117828.
PMID: 39823724 - 6
One PMP22/MPZ and Three MFN2/GDAP1 Concomitant Variants Occurred in a Cohort of 189 Chinese Charcot-Marie-Tooth Families.
Xie Y, Lin Z, Li X, et al.
Frontiers in neurology 2021; (12()):736704 doi:10.3389/fneur.2021.736704.
PMID: 35153971 - 7
[Coincidence of hereditary motor and sensory neuropathy type 1A and limb girdle muscular dystrophy type 2A].
Rudenskaya GE, Bulakh MV, Milovidova TB, Shchagina OA
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2018; (118(11)):72-76 doi:10.17116/jnevro201811811172.
PMID: 30585608
This page explains genetic inheritance of CMT1A for educational purposes only. Always consult a genetic counselor or neurologist for personalized advice, diagnostic testing, and family planning.
Get notified when new evidence is published on Charcot-Marie-Tooth disease type 1A.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.